Acute respiratory viral infections: possibilities of vitamin and mineral complexes in treatment, prevention and rehabilitation

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The present review considers the possibilities of using nutraceuticals for the prevention, treatment and rehabilitation of patients with seasonal acute respiratory viral infections (ARVI) and influenza, as well as with a new coronavirus infection (NCVI). The first part of the review provides data on the potential of microelements (selenium and zinc) and vitamin C as adjuvant therapy in the complex treatment of patients with ARVI, including those with NCVI COVID-19. The second part of the review discusses the possibility of using selenium, zinc, vitamins A, E, C as a means for non-specific prevention of ARVI, as well as the possibility of their use at the stage of rehabilitation. Frequently ill adults are not uncommon in the practice of an internist and general practitioner. The data presented in the review make it possible to recommend determining the levels of selenium, zinc, vitamins A, C, E in this category of patients, and if their reduced level is detected, it is advisable to consider prescribing vitamin-mineral complexes in order to eliminate the deficiency of the main micronutrients.

Full Text

Restricted Access

About the authors

Dmitry I. Trukhan

Omsk State Medical University

Author for correspondence.
Email: dmitry_trukhan@mail.ru
ORCID iD: 0000-0002-1597-1876

Dr. Sci. (Med.), Associate Professor, Professor of the Chair of Polyclinic Therapy and Internal Diseases

Russian Federation, Omsk

I. A. Viktorova

Omsk State Medical University

Email: dmitry_trukhan@mail.ru
ORCID iD: 0000-0001-8728-2722
Russian Federation, Omsk

D. S. Ivanova

Omsk State Medical University

Email: dmitry_trukhan@mail.ru
ORCID iD: 0000-0002-4145-7969
Russian Federation, Omsk

V. V. Goloshubina

Omsk State Medical University

Email: dmitry_trukhan@mail.ru
ORCID iD: 0000-0003-1481-8842
Russian Federation, Omsk

References

  1. Лыткина И.Н., Малышев Н.А. Профилактика и лечение гриппа и острых респираторных вирусных инфекций среди эпидемиологически значимых групп населения. Клиническая инфектология и паразитология. 2015;2(13):117–24.[Lytkina I.N., Malyshev N.A. Prevention and treatment of influenza and acute respiratory viral infections among epidemiologically significant population groups. Klinicheskaya infektologiya i parazitologiya. 2015;2(13):117–24. (In Russ.)].
  2. Трухан Д.И., Филимонов С.Н. Дифференциальный диагноз основных пульмонологических симптомов и синдромов. Санкт-Петербург: СпецЛит, 2019. 176 с. [Trukhan D.I., Filimonov S.N. Differential diagnosis of the main pulmonary symptoms and syndromes. St. Petersburg: SpetsLit, 2019. 176 p. (In Russ.)].
  3. Трухан Д.И., Мазуров А.Л., Речапова Л.А. Острые респираторные вирусные инфекции: актуальные вопросы диагностики, профилактики и лечения в практике терапевта. Терапевтический архив. 2016;11:76–82. [Trukhan D.I., Mazurov A.L., Rechapova L.A. Acute respiratory viral infections: topical issues of diagnosis, prevention and treatment in the practice of a general practitioner. Terapevticheskii arkhiv. 2016;11:76–82. (In Russ.)]. doi: 10.17116/terarkh2016881176-82.
  4. Клинические рекомендации. Острые респираторные вирусные инфекции (ОРВИ) у взрослых. 2021. [Clinical guidelines. Acute respiratory viral infections (ARVI) in adults. 2021. URL: https://cr.minzdrav.gov.ru/recomend/724_1
  5. Клинические рекомендации. Острая респираторная вирусная инфекция (ОРВИ). 2021. [Clinical recommendations. Acute respiratory viral infection (ARVI). 2021. (In Russ.)]. URL: https://cr.minzdrav.gov.ru/recomend/25_2
  6. Гриневич В.Б., Губонина И.В., Дощицин В.Л. и др. Особенности ведения коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19). Национальный консенсус, 2020. Кардиоваскулярная терапия и профилактика. 2020;19(4):2630. [Grinevich V.B., Gubonina I.V., Doshchitsin V.L. et al. Peculiarities of management of comorbid patients during the pandemic of a new coronavirus infection (COVID-19). National Consensus, 2020. Kardiovaskulyarnaya terapiya i profilaktika. 2020;19(4):2630. (In Russ.)]. doi: 10.15829/1728-8800-2020-2630.
  7. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции COVID-19». Версия 17 (14.12.2022)» утв. Минздравом России. [Interim guidelines «Prevention, diagnosis and treatment of a new coronavirus infection COVID-19». Version 17 (12/14/2022)» approved. Ministry of Health of Russia. (In Russ.)]. URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/061/254/original/%D0%92%D0%9C%D0%A0_COVID-19_V17.pdf?1671088207
  8. Трухан Д.И., Давыдов Е.Л. Место и роль терапевта и врача общей практики в курации коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19): акцент на неспецифическую профилактику. Фарматека. 2021;10:34–45. [Trukhan D.I., Davydov E.L. The place and role of a therapist and general practitioner in the management of comorbid patients during the pandemic of the new coronavirus infection (COVID-19): an emphasis on non-specific prevention. Farmateka. 2021;10:34–45. (In Russ.)]. doi: 10.18565/pharmateca.2021.10.34–45.
  9. Трухан Д.И., Давыдов Е.Л., Чусова Н.А., Чусов И.С. Возможности терапевта в профилактике и на реабилитационном этапе после новой коронавирусной инфекции (COVID-19) коморбидных пациентов с артериальной гипертензией. Клинический разбор в общей медицине. 2021;5:6–15. [Trukhan D.I., Davydov E.L., Chusova N.A., Chusov I.S. Opportunities of the therapist in the prevention and rehabilitation phase after a new coronavirus infection (COVID-19) in comorbid patients with arterial hypertension. Klinicheskii razbor v obshchei meditsine. 2021;5:6–15. (In Russ.)]. doi: 10.47407/kr2021.2.5.00064.
  10. Трухан Д.И., Давыдов Е.Л., Чусова Н.А. Нутрицевтики в профилактике, лечении и на этапе реабилитации после новой коронавирусной инфекции (COVID-19). Клинический разбор в общей медицине. 2021;7:21–34. [Trukhan D.I., Davydov E.L., Chusova N.A. Nutraceuticals in the prevention, treatment and rehabilitation phase after a new coronavirus infection (COVID-19). Klinicheskii razbor v obshchei meditsine. 2021;7:21–34. (In Russ.)]. doi: 10.47407/kr2021.2.7.00085.
  11. Трухан Д.И., Турутина Н.М. Витаминно-минеральные комплексы в лечении острых респираторных вирусных инфекций. Клинический разбор в общей медицине. 2022;6:52–60. [Trukhan D.I., Turutina N.M. Vitamin-mineral complexes in the treatment of acute respiratory viral infections. Klinicheskii razbor v obshchei meditsine. 2022;6:52–60. (In Russ.)]. doi: 10.47407/kr2022.3.6.00177.
  12. Трухан Д.И., Давыдов Е.Л. Место и роль терапевта и врача общей практики в курации коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19): акцент на реабилитационный этап. Фарматека. 2021;13:44–53. [Trukhan D.I., Davydov E.L. The place and role of a therapist and general practitioner in the management of comorbid patients during the pandemic of the new coronavirus infection (COVID-19): an emphasis on the rehabilitation stage. Farmateka. 2021;13:44–53. (In Russ.)]. doi: 10.18565/pharmateca.2021.13.44-53.
  13. Трухан Д.И. Коморбидный пациент на терапевтическом приеме в период пандемии COVID-19. Актуальные аспекты реабилитационного периода. Фарматека. 2022;29(13):15–24. [Trukhan D.I. A comorbid patient at a therapeutic reception during the COVID-19 pandemic. current aspects of the rehabilitation period. Farmateka. 2022;29(13):15–24. (In Russ.)]. doi: 10.18565/pharmateca.2022.13.15-24.
  14. Трухан Д.И., Иванова Д.С. Витаминно-минеральные комплексы в профилактике, лечении и на этапе реабилитации после острых респираторных вирусных инфекций и новой коронавирусной инфекции (COVID-19). Клинический разбор в общей медицине. 2022;5:33–46. [Trukhan D.I., Ivanova D.S. Vitamin-mineral complexes in prevention, treatment and rehabilitation after acute respiratory viral infections and new coronavirus infection (COVID-19). Klinicheskii razbor v obshchei meditsine. 2022;5:33–46. (In Russ.)]. doi: 10.47407/kr2022.3.5.00160.
  15. de Faria Coelho-Ravagnani C., Corgosinho F.C., et al. Dietary recommendations during the COVID-19 pandemic. Nutr Rev. 2021;79(4):382–93. doi: 10.1093/nutrit/nuaa067.
  16. Nedjimi B. Can trace element supplementations (Cu, Se, and Zn) enhance human immunity against COVID-19 and its new variants? Beni Suef Univ J Basic Appl Sci. 2021;10(1):33. doi: 10.1186/s43088-021-00123-w.
  17. Yaseen M.O., Jamshaid H., Saif A. Hussain T. mmunomodulatory role and potential utility of various nutrients and dietary components in SARS-CoV-2 infection. Int J Vitam Nutr Res. 2022;92(1):35–48. doi: 10.1024/0300-9831/a000715.
  18. Dharmalingam K., Birdi A., Tomo S., et al. Trace Elements as Immunoregulators in SARS-CoV-2 and Other Viral Infections. Indian J Clin Biochem. 2021 Feb 12:1–11. doi: 10.1007/s12291-021-00961-6.
  19. Martinez S.S., Huang Y., Acuna L., et al. Role of Selenium in Viral Infections with a Major Focus on SARS-CoV-2. Int J Mol Sci. 2021;23(1):280. doi: 10.3390/ijms23010280.
  20. Barchielli G, Capperucci A, Tanini D. The Role of Selenium in Pathologies: An Updated Review. Antioxidants (Basel). 2022;11(2):251. doi: 10.3390/antiox11020251.
  21. Moghaddam A., Heller R.A., Sun Q., et al. Selenium Deficiency Is Associated with Mortality Risk from COVID-19. Nutrients. 2020;12(7):2098. doi: 10.3390/nu12072098.
  22. Bae M., Kim H. Mini-Review on the Roles of Vitamin C, Vitamin D, and Selenium in the Immune System against COVID-19. Molecules. 2020;25(22):5346. doi: 10.3390/molecules25225346.
  23. Bermano G., Meplan C., Mercer D.K., Hesketh J.E. Selenium and viral infection: are there lessons for COVID-19? Br J Nutr. 2021;125(6):618–27. doi: 10.1017/S0007114520003128.
  24. Kieliszek M., Lipinski B. Selenium supplementation in the prevention of coronavirus infections (COVID-19). Med Hypotheses. 2020;143:109878. doi: 10.1016/j.mehy.2020.109878.
  25. Tomo S., Saikiran G., Banerjee M., Paul S. Selenium to selenoproteins - role in COVID-19. EXCLI J. 2021;20:781–91. doi: 10.17179/excli2021-3530.
  26. Schomburg L. Selenium Deficiency in COVID-19-A Possible Long-Lasting Toxic Relationship. Nutrients. 2022;14(2):283. doi: 10.3390/nu14020283.
  27. Schomburg L. Selenoprotein P – Selenium transport protein, enzyme and biomarker of selenium status. Free Radic Biol Med. 2022;191:150–63. doi: 10.1016/j.freeradbiomed.2022.08.022.
  28. Lima L.W., Nardi S., Santoro V., Schiavon M. The Relevance of Plant-Derived Se Compounds to Human Health in the SARS-CoV-2 (COVID-19) Pandemic Era. Antioxidants (Basel). 2021;10(7):1031. doi: 10.3390/antiox10071031.
  29. Im J.H., Je Y.S., Baek J., Chung M.H., Kwon H.Y., Lee JS. Nutritional status of patients with COVID-19. Int J Infect Dis. 2020;100:390–93. doi: 10.1016/j.ijid.2020.08.018.
  30. Younesian O., Khodabakhshi B., Abdolahi N., et al. Decreased Serum Selenium Levels of COVID-19 Patients in Comparison with Healthy Individuals. Biol Trace Elem Res. 2021 Jul 1:1–6. doi: 10.1007/s12011-021-02797-w.
  31. Oliveira C.R., Viana E.T., Goncalves T.F., et al. Therapeutic use of intravenous selenium in respiratory and immunological diseases: evidence based on reviews focused on clinical trials. Adv Respir Med. 2022 Jan 31. doi: 10.5603/ARM.a2022.0018.
  32. Rayman MP, Taylor EW, Zhang J. The relevance of selenium to viral disease with special reference to SARS-CoV-2 and COVID-19. Proc Nutr Soc. 2022 Aug 19:1–12. doi: 10.1017/S0029665122002646.
  33. Shankar A.H., Prasad A.S. Zinc and immune function: the biological basis of altered resistance to infection Am J Clin Nutr 1998;68(2 Suppl):447S–463S. doi: 10.1093/ajcn/68.2.447S.
  34. Overbeck S., Rink L., Haase H. Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases. Arch Immunol Ther Exp (Warsz). 2008;56(1):15–30. doi: 10.1007/s00005-008-0003-8.
  35. Kirkil G., Hamdi Muz M., Seckin D., et al. Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease. Respir Med. 2008 Jun;102(6):840–44. doi: 10.1016/j.rmed.2008.01.010.
  36. Samad N., Sodunke T.E., Abubakar A.R., et al. The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic. J Inflamm Res. 2021;14:527–50. doi: 10.2147/JIR.S295377.
  37. Li J., Cao D., Huang Y., et al. Zinc Intakes and Health Outcomes: An Umbrella Review. Front Nutr. 2022;9:798078. doi: 10.3389/fnut.2022.798078.
  38. Vlieg-Boerstra B., de Jong N., Meyer R., et al. Nutrient supplementation for prevention of viral respiratory tract infections in healthy subjects: A systematic review and meta-analysis. Allergy. 2022;77(5):1373–1388. doi: 10.1111/all.15136.
  39. Kaushik N., Subramani C., Anang S., et al. Zinc salts block hepatitis E virus replication by inhibiting the activity of viral RNA-dependent RNA polymerase. J Virol. 2017;91(21):e00754-17. doi: 10.1128/JVI.00754-17
  40. Skalny A.V., Rink L., Ajsuvakova O.P., et al. Zinc and respiratory tract infections: Perspectives for COVID-19 (Review). Int J Mol Med. 2020;46(1):17-26. doi: 10.3892/ijmm.2020.4575.
  41. Corrao S., Mallaci Bocchio R., Lo Monaco M., et al. Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc. Nutrients. 2021;13(4):1261. doi: 10.3390/nu13041261.
  42. Patel O., Chinni V., El-Khoury J., et al. A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients. J Med Virol. 2021;93(5):3261–67.
  43. Scarpellini E., Balsiger L.M., Maurizi V., et al. Zinc and gut microbiota in health and gastrointestinal disease under the COVID-19 suggestion. Biofactors. 2022;48(2):294-306. doi: 10.1002/biof.1829.
  44. Jothimani D., Kailasam E., Danielraj S., et al. COVID-19: Poor outcomes in patients with zinc deficiency. Int J Infect Dis. 2020;100:343–49. doi: 10.1016/j.ijid.2020.09.014.
  45. Wessels I., Rolles B., Rink L. The Potential Impact of Zinc Supplementation on COVID-19. Pathogenesis. Front Immunol. 2020;11:1712. doi: 10.3389/fimmu.2020.01712.
  46. Wessels I., Rolles B., Slusarenko A.J., Rink L. Zinc deficiency as a possible risk factor for increased susceptibility and severe progression of Corona Virus Disease 19. Br J Nutr. 2022;127(2):214-32. doi: 10.1017/S0007114521000738.
  47. Tabatabaeizadeh S.A. Zinc supplementation and COVID-19 mortality: a meta-analysis. Eur J Med Res. 2022;27(1):70. doi: 10.1186/s40001-022-00694-z.
  48. Rahman M.T., Idid S.Z. Can Zn Be a Critical Element in COVID-19 Treatment? Biol Trace Elem Res. 2021;199(2):550–58. doi: 10.1007/s12011-020-02194-9.
  49. de Almeida Brasiel PG. The key role of zinc in elderly immunity: A possible approach in the COVID-19 crisis. Clin Nutr ESPEN. 2020;38:65-6. doi: 10.1016/j.clnesp.2020.06.003.
  50. Hunter J., Arentz S., Goldenberg J., et al. Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2021;11(11):e047474. doi: 10.1136/bmjopen-2020-047474.
  51. Marreiro D.D.N., Cruz K.J.C., Oliveira A.R.S., et al. Antiviral and immunological activity of zinc and possible role in COVID-19. Br J Nutr. 2022;127(8):1172–79. doi: 10.1017/S0007114521002099.
  52. Taheri S., Asadi S., Nilashi M., et al. A literature review on beneficial role of vitamins and trace elements: Evidence from published clinical studies. J Trace Elem Med Biol. 2021 Sep;67:126789. doi: 10.1016/j.jtemb.2021.126789.
  53. Junaid K., Ejaz H., Abdalla A.E., et al. Effective Immune Functions of Micronutrients against SARS-CoV-2. Nutrients. 2020;12(10):2992. doi: 10.3390/nu12102992.
  54. Nedjimi B. Can trace element supplementations (Cu, Se, and Zn) enhance human immunity against COVID-19 and its new variants? Beni Suef Univ J Basic Appl Sci. 2021;10(1):33. doi: 10.1186/s43088-021-00123-w.
  55. Engin A.B., Engin E.D., Engin A. Can iron, zinc, copper and selenium status be a prognostic determinant in COVID-19 patients? Environ Toxicol Pharmacol. 2022;95:103937. doi: 10.1016/j.etap.2022.103937.
  56. Alexander J, Tinkov A., Strand T.A., et al. Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raising Anti-Viral Resistance Against Progressive COVID-19. Nutrients. 2020;12(8):2358. doi: 10.3390/nu12082358.
  57. Abioye A.I., Bromage S., Fawzi W. Effect of micronutrient supplements on influenza and other respiratory tract infections among adults: a systematic review and meta-analysis. BMJ Glob Health. 2021;6(1):e003176. doi: 10.1136/bmjgh-2020-003176.
  58. Diyya A.S.M., Thomas N.V. Multiple Micronutrient Supplementation: As a Supportive Therapy in the Treatment of COVID-19. Biomed Res Int. 2022;2022:3323825. doi: 10.1155/2022/3323825.
  59. Hemila H., Douglas R.M. Vitamin C and acute respiratory infections. Int J Tuberc Lung Dis. 1999;3(9):756–61.
  60. Hemila H. Vitamin C and common cold incidence: a review of studies with subjects under heavy physical stress. Int J Sports Med. 1996;17(5):379–83. doi: 10.1055/s-2007-972864.
  61. Swain R.A., Kaplan B. Upper respiratory infections: treatment selection for active patients. Phys Sportsmed. 1998;26(2):85–96. doi: 10.3810/psm.1998.02.944.
  62. Khaw K.T., Woodhouse P. Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. BMJ. 1995;310(6994):1559–63. doi: 10.1136/bmj.310.6994.1559.
  63. Ильичева Т.Н., Нетесов С.В., Абубакирова О.А., Гуреев В.Н. Респираторные вирусные инфекции и их роль в сердечно-сосудистых заболеваниях человека. Сибирский журнал клинической и экспериментальной медицины. 2022;37(4):14–21. [Il’icheva T.N., Netesov S.V., Abubakirova O.A., Gureev V.N. Respiratory viral infections and their role in human cardiovascular diseases. Sibirskii zhurnal klinicheskoi i eksperimental’noi meditsiny. 2022;37(4):14–21. (In Russ.)]. (In Russ.)]. doi: 10.29001/2073-8552-2022-37-4-14-21
  64. Ишмурзин Г.П., Серебрякова О.А., Сюзев К.Н. и др. Осложнения со стороны сердечно-сосудистой системы при респираторных вирусных инфекциях. Сибирский журнал клинической и экспериментальной медицины. 2022;37(4):31–7. [Ishmurzin G.P., Serebryakova O.A., Syuzev K.N. Complications of the cardiovascular system in respiratory viral infections. Sibirskii zhurnal klinicheskoi i eksperimental’noi meditsiny. 2022;37(4):31–7. (In Russ.)]. doi: 10.29001/2073-8552-2022-37-4-31-37
  65. Shahbaz U., Fatima N., Basharat S., et al. Role of vitamin C in preventing of COVID-19 infection, progression and severity. AIMS Microbiol. 2022;8(1):108–24. doi: 10.3934/microbiol.2022010.
  66. Ebrahimzadeh-Attari V., Panahi G., Hebert J.R., et al. Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals. Health Promot Perspect. 2021;11(2):119–36. doi: 10.34172/hpp.2021.17.
  67. Abobaker A., Alzwi A., Alraied A.H.A. Overview of the possible role of vitamin C in management of COVID-19. Pharmacol Rep. 2020;72(6):1517–28. doi: 10.1007/s43440-020-00176-1.
  68. Uddin M.S., Millat M.S., Baral P.K., et al. The protective role of vitamin C in the management of COVID-19: A Review. J Egypt Public Health Assoc. 2021;96(1):33. doi: 10.1186/s42506-021-00095-w.
  69. Firouzi S., Pahlavani N., Navashenaq J.G., et al. The effect of Vitamin C and Zn supplementation on the immune system and clinical outcomes in COVID-19 patients. Clin Nutr Open Sci. 2022;44:144–54. doi: 10.1016/j.nutos.2022.06.006.
  70. Carr A.C., Gombart A.F. Multi-Level Immune Support by Vitamins C and D during the SARS-CoV-2 Pandemic. Nutrients. 2022;14(3):689. doi: 10.3390/nu14030689.
  71. Stephensen C.B., Lietz G. Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2. Br J Nutr. 2021;126(11):1663–72. doi: 10.1017/S0007114521000246
  72. Tepasse P.R., Vollenberg R., Fobker M., et al. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Nutrients. 2021;13(7):2173. doi: 10.3390/nu13072173.
  73. Iddir M., Brito A., Dingeo G., et al. Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis. Nutrients. 2020;12(6):1562. doi: 10.3390/nu12061562.
  74. Tavakol S., Seifalian A.M. Vitamin E at a high dose as an anti-ferroptosis drug and not just a supplement for COVID-19 treatment. Biotechnol Appl Biochem. 2021:10.1002/bab.2176. doi: 10.1002/bab.2176.
  75. Lai Y.J., Chang H.S., Yang Y.P., et al. The role of micronutrient and immunomodulation effect in the vaccine era of COVID-19. J Chin Med Assoc. 2021;84(9):821–26. doi: 10.1097/JCMA.0000000000000587.
  76. Rataan A.O., Geary S.M., Zakharia Y., et al. Potential Role of Selenium in the Treatment of Cancer and Viral Infections. Int J Mol Sci. 2022;23(4):2215. doi: 10.3390/ijms23042215.
  77. Midha I.K., Kumar N., Kumar A., Madan T. Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings. Rev Med Virol. 2021;31(5):1–14. doi: 10.1002/rmv.2204.
  78. Campagnolo N., Johnston S., Collatz A., et al. Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review. J Hum Nutr Diet. 2017;30(3):247–59. doi: 10.1111/jhn.12435.
  79. Bjorklund G., Dadar M., Pen J.J., et al. Chronic fatigue syndrome (CFS): Suggestions for a nutritional treatment in the therapeutic approach. Biomed Pharmacother. 2019;109:1000–7. doi: 10.1016/j.biopha.2018.10.076.
  80. Maksoud R., Balinas C., Holden S., et al. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. 2021;19(1):81. doi: 10.1186/s12967-021-02742-4.
  81. Ostojic S.M. Diagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome. Nutrients. 2021;13(2):503. doi: 10.3390/nu13020503.
  82. Logan A.C., Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern Med Rev. 2001;6(5):450–59.
  83. Poenaru S., Abdallah S.J., Corrales-Medina V., Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis. 2021;8:20499361211009385. doi: 10.1177/20499361211009385.
  84. Vecchiet J., Cipollone F., Falasca K., et al. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett. 2003;335(3):151–54. doi: 10.1016/s0304-3940(02)01058-3.
  85. Maggini S., Ovari V., Ferreres Gimenez I., Pueyo Alaman M.G. Benefits of micronutrient supplementation on nutritional status, energy metabolism, and subjective wellbeing. Nutr Hosp. 2021;38(Spec No2):3–8. doi: 10.20960/nh.03788.
  86. Maes M., Mihaylova I., De Ruyter M. Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. J Affect Disord. 2006;90(2–3):141–47. doi: 10.1016/j.jad.2005.11.002.
  87. Castro-Marrero J., Zaragoza M.C., Lopez-Vilchez I., et al. Effect of Melatonin Plus Zinc Supplementation on Fatigue Perception in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Antioxidants (Basel). 2021;10(7):1010. doi: 10.3390/antiox10071010.
  88. Shao C., Song J., Zhao S., et al. Therapeutic Effect and Metabolic Mechanism of A Selenium-Polysaccharide from Ziyang Green Tea on Chronic Fatigue Syndrome. Polymers (Basel). 2018;10(11):1269. doi: 10.3390/polym10111269.
  89. Beligaswatta C., Sudusinghe D., De Silva S., Davenport A. Prevalence and correlates of low plasma selenium concentrations in peritoneal dialysis patients. J Trace Elem Med Biol. 2022;69:126899. doi: 10.1016/j.jtemb.2021.126899.
  90. Miwa K., Fujita M. Increased oxidative stress suggested by low serum vitamin E concentrations in patients with chronic fatigue syndrome. Int J Cardiol. 2009;136(2):238–39. doi: 10.1016/j.ijcard. 2008.04.051.
  91. Miwa K., Fujita M. Fluctuation of serum vitamin E (alpha-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome. Heart Vessels. 2010;25(4):319–23. doi: 10.1007/s00380-009-1206-6.
  92. Joustra M.L., Minovic I., Janssens K.A.M., et al. Vitamin and mineral status in chronic fatigue syndrome and fibromyalgia syndrome: A systematic review and meta-analysis. PLoS One. 2017;12(4):e0176631. doi: 10.1371/journal.pone.0176631.
  93. Kodama M., Kodama T. Four problems with the clinical control of interstitial pneumonia, or chronic fatigue syndrome, using the megadose vitamin C infusion system with dehydroepiandrosterone-cortisol annex. In Vivo. 2006;20(2):285–91.
  94. Балаболкин И.И., Булгакова В.А., Ушако-ва В.В. Современное состояние проблемы часто болеющих детей. Педиатрическая фармакология. 2007;2:48–52. [Balabolkin I.I., Bulgakova V.A., Ushakova V.V. The current state of the problem of frequently ill children. Pediatricheskaya farmakologiya. 2007;2:48–52. (In Russ.)].
  95. Трухан Д.И., Тарасова Л.В. Особенности клиники и лечения острых респираторных вирусных инфекций в практике врача-терапевта. Врач. 2014;8:44–7. [Trukhan D.I, Tarasova L.V. Features of the clinic and treatment of acute respiratory viral infections in the practice of a general practitioner. Vrach. 2014;8:44–7. (In Russ.)].
  96. Трухан Д.И., Филимонов С.Н., Багишева Н.В. Болезни органов дыхания: актуальные аспекты клиники, диагностики и лечения. Санкт-Петербург: СпецЛит, 2022. 286 с. [Trukhan D.I., Filimonov S.N., Bagisheva N.V. Respiratory diseases: current aspects of the clinic, diagnosis and treatment. St. Petersburg: SpetsLit, 2022. 286 p. (In Russ.)].
  97. Трухан Д.И. Новая коронавирусная инфекция (COVID-19) и заболевания. патологические состояния органов дыхания. Медицинский совет. 2022;16(18):154–61. [Trukhan D.I. New coronavirus infection (COVID-19) and diseases. pathological conditions of the respiratory system. Meditsinskii sovet. 2022;16(18):154–61. (In Russ.)]. doi: 10.21518/2079-701X-2022-16-18- 154-161.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies